Xoma | XOMA - Pre Tax Profit

Stock Price
41.75
Daily Change
-0.25 -0.60%
Monthly
5.40%
Yearly
54.69%
Q2 Forecast
40.91

Xoma reported $15.98M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Agenus USD -10.61M 263.52M Dec/2025
Agios Pharmaceuticals USD -99.11M 9.94M Mar/2026
Ardelyx USD -400K 467K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
BioMarin Pharmaceutical USD 141.2M 168.36M Mar/2026
Celldex Therapeutics USD -81.32M 14.27M Dec/2025
Curis USD 19.36M 33.34M Dec/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
Incyte USD 343.6M 46.34M Mar/2026
MacroGenics USD -14.93M 31.75M Dec/2025
Novartis USD 3.84B 802M Mar/2026
Novartis USD 5.17B 637M Sep/2025
Pfizer USD 5.18B 6.82B Mar/2026
Prothena USD -21.58M 15.33M Dec/2025
Regeneron Pharmaceuticals USD 1.04B 719.6M Dec/2025
Xoma USD 15.98M 24.58M Jun/2024